CRISM THERAPEUTICS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.75 GBX | -4.55% |
|
+200.00% | +9.38% |
| 07-04 | Crism Therapeutics Affirms Plan to File Clinical Trial Application for Lead Product in H2 | MT |
| 07-03 | Crism flags contract talks, reacts to share price surge | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.76M | - | - | - | - | - | |
| 823B | ||||||
| 627B | ||||||
| 353B | - | - | - | - | ||
| 320B | ||||||
| 295B |
